Edesa Biotech
EDSA----
Edesa Biotech (EDSA)
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical p...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Edesa Biotech Analyst Rating
View MoreForecast & Rating
Jul 2, 2026Price forecast
$16.33211.11%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Jul 23 at 11:40 PM
Edesa Biotech (NASDAQ:EDSA) Shares Down 0.4% - Should You Sell?
- rttnews · Jun 23 at 10:15 PM
Top Biotech Gainers: BOLD Begins Anew, MNPR NDA Filing On Track, GALT Soars On FDA Alignment
- StockTitan · Jun 11 at 12:15 AM
Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors | EDSA Stock News
- StockTitan · Jun 5 at 12:20 AM
Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury | EDSA Stock News
- rttnews · May 20 at 04:04 AM
MTVA Gains Weight, CODX Takes A Shot At Ebola, EDSA To Reveal New Data, BDTX On Watch
- benzinga_article · May 19 at 12:06 PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
